User profiles for Sanjeep S.V. Golla

Sandeep SV Golla

Assistant Professor, VU University Medical Centre
Verified email at vumc.nl
Cited by 1125

Quantification of [18F]DPA-714 Binding in the Human Brain: Initial Studies in Healthy Controls and Alzheimer'S Disease Patients

SSV Golla, R Boellaard, V Oikonen… - Journal of Cerebral …, 2015 - journals.sagepub.com
Fluorine-18 labelled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-α]pyrimidine-3-yl)acetamide
([ 18 F] DPA-714) binds to the 18-kDa translocator protein (TSPO) …

Multitracer model for staging cortical amyloid deposition using PET imaging

…, M van Buchem, M Yaqub, P Markiewicz, SSV Golla… - Neurology, 2020 - AAN Enterprises
Objective To develop and evaluate a model for staging cortical amyloid deposition using
PET with high generalizability. Methods Three thousand twenty-seven individuals (1,763 …

[HTML][HTML] In vivo tau pathology is associated with synaptic loss and altered synaptic function

…, F Barkhof, P Scheltens, SSV Golla… - Alzheimer's research & …, 2021 - Springer
Background The mechanism of synaptic loss in Alzheimer’s disease is poorly understood
and may be associated with tau pathology. In this combined positron emission tomography (…

[HTML][HTML] The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

MHJ Hagens, SSV Golla, B Janssen, DJ Vugts… - European journal of …, 2020 - Springer
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in
multiple sclerosis: a first-in man study | European Journal of Nuclear Medicine and Molecular …

A head-to-head comparison between plasma pTau181 and Tau PET along the Alzheimer's disease continuum

…, T Timmers, AD Windhorst, SSV Golla… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Both plasma tau phosphorylated at threonine-181 (pTau181) and tau PET show potential
for detecting Alzheimer’s disease (AD) pathology and predicting clinical progression. In this …

[HTML][HTML] Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum

…, EE Wolters, SCJ Verfaillie, D Visser, SSV Golla… - Alzheimer's research & …, 2019 - Springer
Background Neuropathological studies have linked tau aggregates to neuronal loss. To
describe the spatial distribution of neurofibrillary tangle pathology in post-mortem tissue, Braak …

[HTML][HTML] Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease

…, T Timmers, D Visser, H Tuncel, SSV Golla… - European journal of …, 2020 - Springer
Purpose In vivo Alzheimer’s disease (AD) biomarkers for tau pathology are cerebrospinal
fluid (CSF) phosphorylated tau (p-tau) and [ 18 F]flortaucipir positron emission tomography (…

Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET

D Visser, SSV Golla, SCJ Verfaillie, EM Coomans… - medRxiv, 2022 - medrxiv.org
A significant number of COVID-19 patients develop ‘long COVID’, a condition defined by
long-lasting debilitating, often neurological, symptoms. The pathophysiology of long COVID is …

[HTML][HTML] Quantification of Tau Load Using [18F]AV1451 PET

SSV Golla, T Timmers, R Ossenkoppele… - Molecular imaging and …, 2017 - Springer
Purpose The tau tracer [ 18 F]AV1451, also known as flortaucipir, is a promising ligand for
imaging tau accumulation in Alzheimer’s disease (AD). Most of the previous studies have …

[HTML][HTML] An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

MC Ferrández, SSV Golla, JJ Eertink, BM de Vries… - Scientific Reports, 2023 - nature.com
Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-cell
lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN …